Search filters

List of works by Mitch A Phelps

A dose-finding, pharmacokinetic and pharmacodynamic study of a novel schedule of flavopiridol in patients with advanced solid tumors ⬇️

scientific article published on October 12, 2010

A novel liposomal formulation of FTY720 (Fingolimod) for promising enhanced targeted delivery ⬇️

scientific article published on August 20, 2013

A novel liposomal formulation of flavopiridol

scientific article published on 20 August 2008

A pharmacokinetic/pharmacodynamic model of tumor lysis syndrome in chronic lymphocytic leukemia patients treated with flavopiridol

scientific article published on 08 January 2013

A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome

scientific article published on 10 August 2020

A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors ⬇️

scientific article published on July 31, 2012

Analysis of the transport of and cytotoxic effects for nalbuphine solution in corneal cells ⬇️

scientific article published on December 1, 2012

CYP3A4/5 combined genotype analysis for predicting statin dose requirement for optimal lipid control ⬇️

scientific article published on January 1, 2013

Cachectic Cancer Patients: Immune to Checkpoint Inhibitor Therapy?

scientific article published on 17 July 2018

Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia

scientific article

Comparative cellular pharmacokinetics and pharmacodynamics of siRNA delivery by SPANosomes and by cationic liposomes ⬇️

scientific article published on October 29, 2012

Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemia ⬇️

scientific article published on July 15, 2013

Development and validation of a highly sensitive liquid chromatography/mass spectrometry method for simultaneous quantification of lenalidomide and flavopiridol in human plasma

scientific article

Development and validation of sensitive liquid chromatography/tandem mass spectrometry method for quantification of bendamustine in mouse brain tissue ⬇️

scientific article published on August 16, 2012

Dose escalation of lenalidomide in relapsed or refractory acute leukemias

scientific article

Early intervention with lenalidomide in patients with high-risk chronic lymphocytic leukemia

scientific article published on 21 September 2020

Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia

scientific article published on 26 September 2006

Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkin's lymphoma

scientific article

Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach

scientific article published on 22 January 2012

Institutional Profile: Program in Pharmacogenomics at the Ohio State University Medical Center ⬇️

scientific article published on May 1, 2012

Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies

scientific article published on 03 December 2012

Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers ⬇️

scientific article published on April 25, 2011

Optimising time samples for determining area under the curve of pharmacokinetic data using non-compartmental analysis

scientific article published on 14 August 2019

Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.

scientific article published on 7 September 2017

Pharmacokinetics and Tissue Disposition of Lenalidomide in Mice ⬇️

scientific article published on September 7, 2012

Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia

scientific article published on 24 January 2013

Pharmacokinetics of methylprednisolone acetate after intra-articular administration and subsequent suppression of endogenous hydrocortisone secretion in exercising horses ⬇️

scientific article published on 01 September 2012

Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias

scientific article

Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease

scientific article published on 13 October 2009

Phyllanthusmin Derivatives Induce Apoptosis and Reduce Tumor Burden in High-Grade Serous Ovarian Cancer by Late-Stage Autophagy Inhibition

scientific article published on 17 July 2018

Population pharmacokinetics of lenalidomide in patients with B-cell malignancies

scientific article published on 27 February 2019

Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL)

scientific article

Registered report: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs

scientific article

Replication Study: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs

scientific article published on 19 October 2020

Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells

scientific article

Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol ⬇️

scientific article published on May 24, 2011

Rituximab immunotherapy: it's getting personal.

scientific article

SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune Evasion

scientific article published on 04 January 2019

The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma

scientific article

miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival ⬇️

scientific article published on October 18, 2011

Paulina is supported by:

About Paulina

Help